Jamshedpur 9 April: A COVID-19 testing kit made by Molbio Diagnostics Pvt Ltd, has been approved by the Indian Council of Medical Research (ICMR).
“ICMR has recommended use of Truenat beta CoV test on Truelab workstation validated by ICMR as a screening test,” ICMR has stated in its guidance
The initiative was supported by India Health Fund, through the Centre for Health Research and Innovations (CHRI). The testing kit — the Truenat Beta CoV test — to be used by patients to test for COVID-19. This kit will be used as a screening test for COVID-19, with test results available within an hour.
This will enable same-day testing, reporting, and initiation of patient isolation, if required – thereby reducing the risk of infection spreading while waiting for results. The cost of each test is under Rs 1,350. Truenat Beta CoV test is the second Made-In-India diagnostic solution that has been approved for use by ICMR in a short span of time.
India Health Fund is an organisation seeded by Tata Trusts to identify and support breakthrough innovations, which will help accelerate the elimination of infectious diseases in India.
Dr. Chandrashekhar Nair, Chief Technical Officer at Molbio Diagnostics Pvt. Ltd, pointed out, “The need of the hour is to augment access to molecular diagnostics in a fast-track mode with required financial support which will help in better preparedness to tackle in controlling pandemics like COVID-19 and outbreaks in future”.